Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines,
The Senior Medical Director, Oncology Clinical Development - GU will report to the Executive Medical Director, Clinical Development Lead (CDL), Oncology Clinical Development. The Sr. Medical Director will be responsible for clinical research activities pertaining to
Position Summary GSK is committed to transforming outcomes for people with cancer through innovative science, bold ambition, and strong partnerships across the healthcare ecosystem. The Clinical Development Lead (CDL) – Oncology operates at the asset level
About EDV Werke: EDV Werke is a Tech Consulting and Services company. We expertise around SAP and High-Tech – Industry 4.0. Our dedicated teams offer services such as Service Desk, Software Development, and Data Solutions. Our
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our
Senior Counsel / Senior Investment Funds Lawyer | Baar (Zug), Switzerland Our client, a leading global private markets investment platform, is seeking an experienced Senior Investment Funds Lawyer to join its structuring team based in Zug, Switzerland.
Senior Counsel / Senior Investment Fund Lawyer Location: Baar, CH We are one of the largest global private markets investment managers, serving over 800 institutional investors worldwide. We have USD 185 billion in assets under management
The Senior Medical Director, Oncology Clinical Development - GU will report to the Executive Medical Director, Clinical Development Lead (CDL), Oncology Clinical Development. The Sr. Medical Director will be responsible for clinical research activities pertaining to
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our